Beacon Roofing Supply to buy back about $805 million in stock from Clayton, Dubilier & Rice
Beacon Roofing Supply Inc. (BECN) stock is up 0.8% in premarket trades Friday after the company said it plans to repurchase 400,000 shares of Series A preferred stock from private equity firm Clayton, Dubilier & Rice (CD&R) for $804.5 million plus accrued and unpaid dividends. The deal will reduce the company's diluted share count on an as-converted basis by 9.69 million shares and eliminate preferred dividends of $24 million per year, while simplifying the company's capital structure, the company said. CD&R will continue to own 15.2 million shares of common stock. Beacon Roofing said it expects to report second-quarter earnings of$1.88 to $1.97 a share, compared to the analyst forecast of $2.21 a share, according to estimates compiled by FactSet. It's projecting second-quarter net sales of $2.5 billion, ahead of the analyst estimate of $2.44 billion.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-07-23 0749ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters